Mail

UK markets closed

FTSE 100
8,139.83
+60.97(+0.75%)
FTSE 250
19,824.16
+222.18(+1.13%)
AIM
755.28
+2.16(+0.29%)
GBP/EUR
1.1677
+0.0020(+0.17%)
GBP/USD
1.2493
-0.0018(-0.15%)
Bitcoin GBP
51,069.76
-658.81(-1.27%)

9 luxury homes to consider if money is no object

Ever thought about what a multimillion pound budget would buy you?

AstraZeneca PLC (AZN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Add to watchlist

75.32

+0.29

(+0.39%)

As of 03:48PM EDT. Market open.

Currency in USD

Valuation measures⁴

Market cap (intra-day)	232.27B
Enterprise value	258.80B
Trailing P/E	37.05
Forward P/E	17.83
PEG ratio (5-yr expected)	0.96
Price/sales (ttm)	4.92
Price/book (mrq)	6.21
Enterprise value/revenue	5.44
Enterprise value/EBITDA	18.81

Trading information

Stock price history

Beta (5Y monthly)	0.19
52-week change ³	2.47%
S&P500 52-week change ³	21.08%
52-week high ³	75.81
52-week low ³	60.47
50-day moving average ³	66.90
200-day moving average ³	66.76

Share statistics

Avg vol (3-month) ³	6.38M
Avg vol (10-day) ³	6.89M
Shares outstanding ⁵	3.1B
Implied shares outstanding ⁶	3.12B
Float ⁸	1.54B
% held by insiders ¹	0.00%
% held by institutions ¹	16.85%
Shares short (15 Apr 2024) ⁴	8.58M
Short ratio (15 Apr 2024) ⁴	1.61
Short % of float (15 Apr 2024) ⁴	N/A
Short % of shares outstanding (15 Apr 2024) ⁴	0.28%
Shares short (prior month 15 Mar 2024) ⁴	10.48M

Dividends & splits

Forward annual dividend rate ⁴	1.45
Forward annual dividend yield ⁴	1.93%
Trailing annual dividend rate ³	2.90
Trailing annual dividend yield ³	3.87%
5-year average dividend yield ⁴	2.52
Payout ratio ⁴	71.60%
Dividend date ³	25 Mar 2024
Ex-dividend date ⁴	22 Feb 2024
Last split factor ²	2:1
Last split date ³	27 Jul 2015

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Mar 2024

Profitability

Profit margin	13.30%
Operating margin (ttm)	26.11%

Management effectiveness

Return on assets (ttm)	7.04%
Return on equity (ttm)	17.29%

Income statement

Revenue (ttm)	47.61B
Revenue per share (ttm)	2.55
Quarterly revenue growth (yoy)	16.50%
Gross profit (ttm)	N/A
EBITDA	15.8B
Net income avi to common (ttm)	6.33B
Diluted EPS (ttm)	2.03
Quarterly earnings growth (yoy)	20.90%

Balance sheet

Total cash (mrq)	8.02B
Total cash per share (mrq)	5.18
Total debt (mrq)	34.69B
Total debt/equity (mrq)	92.51%
Current ratio (mrq)	0.89
Book value per share (mrq)	24.17

Cash flow statement

Operating cash flow (ttm)	9.7B
Levered free cash flow (ttm)	8.68B